- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT04371419
COVID-19 Health Messaging to Underserved Communities
Studie Overzicht
Gedetailleerde beschrijving
The following procedures will be followed. The research subjects will participate online.
- Doctors from MGH who express interest in participating will record messages according to our scripts (US Doctors Script African American, US Doctors Script Latinx). They will be instructed to film several different versions each.
- We will recruit a sample of Latinx and African American study participants from across the country through Lucid, an online survey firm that has access to a large subject pool.
- Participants will first read a consent script and give us their informed consent (US Doctors Messaging Consent)
Participants will then navigate through the following steps
- Brief demographics survey questions (US Doctors Messaging Survey)
- Videos 1 and 2: Introduction, Acknowledgement, Social Distancing (US Doctors Script African American, US Doctors Script Latinx). Individuals in the control group will not see videos.
- Beliefs survey questions (US Doctors Messaging Survey)
- Video 3: Masks (US Doctors Script African American, US Doctors Script Latinx). Again, individuals in the control group will not see a video here.
- Main outcomes survey (US Doctors Messaging Survey)
- Control group is shown a version of all 3 videos at end (US Doctors Script African American, US Doctors Script Latinx).
The video messages each participant in one of the treatment groups sees will be randomized on the following dimensions. The different versions are clearly demarcated in the US Doctors Scripts document.
- Racial or ethnic identity of the doctor delivering the messages: concordant vs. discordant identity to the subject.
- Whether the message includes an acknowledgment of "elephant in the room" issues for each target group: trust in the medical system or fear of deportation.
- Whether the social distancing component of the message is delivered by Dr. Birx of the CDC or recorded by the MGH physicians.
- Whether individuals are given information about how representative individuals perceive mask wearers of color. This information comes from results of our nationally representative pilot survey.
- Some individuals in a control group will only see messages after all surveying has been completed.
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
Massachusetts
-
Cambridge, Massachusetts, Verenigde Staten, 02138
- JPAL North America
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Preventie
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
---|---|
Experimenteel: Control - CDC - Mask (Control) - Concordant
Control Intro, CDC Social Distancing, Mask Control version delivered by minority doctor of same background as the recipient - other definitions are similar
|
o The video messages each participant in one of the treatment groups sees will be randomized on the following dimensions. The different versions are clearly demarcated in the US Doctors Scripts document.
|
Experimenteel: Control - CDC - Mask (Control) - Discordant
Control Intro, CDC Social Distancing, Mask Control version delivered by majority doctor of different background as the recipient - other definitions are similar
|
o The video messages each participant in one of the treatment groups sees will be randomized on the following dimensions. The different versions are clearly demarcated in the US Doctors Scripts document.
|
Experimenteel: Control - MGH - Mask (Control) - Concordant
Control Intro, MGH Social Distancing, Mask Control version delivered by concordant doctor
|
o The video messages each participant in one of the treatment groups sees will be randomized on the following dimensions. The different versions are clearly demarcated in the US Doctors Scripts document.
|
Experimenteel: Control - MGH - Mask (Control) - Discordant
Control Intro, MGH Social Distancing, Mask Control version delivered by discordant doctor
|
o The video messages each participant in one of the treatment groups sees will be randomized on the following dimensions. The different versions are clearly demarcated in the US Doctors Scripts document.
|
Experimenteel: Ack. Discrimination- MGH - Mask (Control) - Concordant
Introduction Acknowledges past discrimination, MGH doctor talks about Social Distancing, Mask Control all by concordant MD
|
o The video messages each participant in one of the treatment groups sees will be randomized on the following dimensions. The different versions are clearly demarcated in the US Doctors Scripts document.
|
Experimenteel: Ack. Discrimination- MGH - Mask (Control) - Discordant
Introduction Acknowledges past discrimination, MGH doctor talks about Social Distancing, Mask Control all by discordant MD
|
o The video messages each participant in one of the treatment groups sees will be randomized on the following dimensions. The different versions are clearly demarcated in the US Doctors Scripts document.
|
Experimenteel: Ack. econ. circumstance- MGH - Mask (Control ) Concordant
Intro econ.
circumstance -MGH - Mask (Control ) Concordant
|
o The video messages each participant in one of the treatment groups sees will be randomized on the following dimensions. The different versions are clearly demarcated in the US Doctors Scripts document.
|
Experimenteel: Ack. econ. circumstance - MGH - Mask (Control ) Discordant
|
o The video messages each participant in one of the treatment groups sees will be randomized on the following dimensions. The different versions are clearly demarcated in the US Doctors Scripts document.
|
Experimenteel: Control Intro - CDC - Mask (antiStigma) Concordant
Control Intro - CDC - Mask (antiStigma) Concordant messenger
|
o The video messages each participant in one of the treatment groups sees will be randomized on the following dimensions. The different versions are clearly demarcated in the US Doctors Scripts document.
|
Experimenteel: Control Intro - CDC - Mask (antiStigma) Discordant
Control Intro - CDC - Mask (antiStigma) discordant messenger
|
o The video messages each participant in one of the treatment groups sees will be randomized on the following dimensions. The different versions are clearly demarcated in the US Doctors Scripts document.
|
Experimenteel: Control - MGH - MaskS (antiStigma) Concordant messenger
Control - MGH - MaskS (antiStigma) Concordant sender
|
o The video messages each participant in one of the treatment groups sees will be randomized on the following dimensions. The different versions are clearly demarcated in the US Doctors Scripts document.
|
Experimenteel: Control- MGH-MaskS (antiStigma) Discordant messenger
Control - MGH - MaskS (antiStigma) Discordant sender
|
o The video messages each participant in one of the treatment groups sees will be randomized on the following dimensions. The different versions are clearly demarcated in the US Doctors Scripts document.
|
Experimenteel: Ack. Discrimination - MGH - MaskS (antiStigma) Concordant
Acknowledge Discrimination - MGH - MaskS (antiStigma) Concordant sender
|
o The video messages each participant in one of the treatment groups sees will be randomized on the following dimensions. The different versions are clearly demarcated in the US Doctors Scripts document.
|
Experimenteel: Ack. Discrimination - MGH - MaskS (antiStigma) Discordant
Acknowledge Discrimination - MGH - MaskS (antiStigma) Discordant sender
|
o The video messages each participant in one of the treatment groups sees will be randomized on the following dimensions. The different versions are clearly demarcated in the US Doctors Scripts document.
|
Experimenteel: Ack. Econ Hardship- MGH - Mask (antiStigma) Concordant
Acknowledge Econ Hardship- MGH - Mask (antiStigma) Concordant sender
|
o The video messages each participant in one of the treatment groups sees will be randomized on the following dimensions. The different versions are clearly demarcated in the US Doctors Scripts document.
|
Experimenteel: Ack. Econ Hardship- MGH - Mask (antiStigma) Discordant
Acknowledge Econ Hardship- MGH - Mask (antiStigma) discordant sender
|
o The video messages each participant in one of the treatment groups sees will be randomized on the following dimensions. The different versions are clearly demarcated in the US Doctors Scripts document.
|
Placebo-vergelijker: Info later - Pure Control
This group will not receive the videos but will receive information later.
|
o The video messages each participant in one of the treatment groups sees will be randomized on the following dimensions. The different versions are clearly demarcated in the US Doctors Scripts document.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
Incidence Rate for Knowledge Gaps: Control vs. Any Intervention
Tijdsspanne: The outcome was measured immediately following the intervention in the 15-minute baseline survey.
|
Incidence rate for knowledge gaps is the count of knowledge gaps divided by the maximum possible count: 7
|
The outcome was measured immediately following the intervention in the 15-minute baseline survey.
|
Incidence Rate for Information-seeking Behavior: Control vs. Any Intervention
Tijdsspanne: The outcome was measured immediately following the intervention in the 15-minute baseline survey.
|
Incidence rate for Information-seeking behavior is the count of links demanded divided by the maximum possible count: 10
|
The outcome was measured immediately following the intervention in the 15-minute baseline survey.
|
Incidence Rate for Knowledge Gaps by Intervention
Tijdsspanne: The outcome was measured immediately following the intervention in the 15-minute baseline survey.
|
Incidence rate for knowledge gaps is the count of knowledge gaps divided by the maximum possible count: 7
|
The outcome was measured immediately following the intervention in the 15-minute baseline survey.
|
Incidence Rate for Information-seeking Behavior by Intervention
Tijdsspanne: The outcome was measured immediately following the intervention in the 15-minute baseline survey.
|
Incidence rate for Information-seeking behavior is the count of links demanded divided by the maximum possible count: 10
|
The outcome was measured immediately following the intervention in the 15-minute baseline survey.
|
Medewerkers en onderzoekers
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 2003000118
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
IPD-tijdsbestek voor delen
IPD-toegangscriteria voor delen
IPD delen Ondersteunend informatietype
- SAP
- ANALYTIC_CODE
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Coronavirus
-
Beijing Ditan HospitalOnbekend
-
Bursa Yüksek İhtisas Education and Research HospitalOnbekendCoronavirus als oorzaak van elders geclassificeerde ziektenKalkoen
-
Maimonides Medical CenterBeëindigdCOVID, CoronavirusVerenigde Staten
-
NPO PetrovaxVoltooidInfecties, coronavirusWit-Rusland, Russische Federatie
-
King Hussein Cancer CenterACDIMA Biocenter; Sana Pharmaceutical Industry; Amman Pharmaceutical Industries...IngetrokkenNieuw coronavirus uit 2019Jordanië
-
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.Actief, niet wervend
-
T.C. ORDU ÜNİVERSİTESİVoltooidTURKISH VALIDITY AND RELIABILITY STUDY OF THE CORONAVIRUS IMPACT SCALEKalkoen
-
University Hospital, Basel, SwitzerlandsciCORE University of Basel; Leonhard Med IT ETH Zurich; Swiss Institute of BioinformaticsWervingSARS Coronavirus (SARS-CoV-2) infectieZwitserland
-
National Institute of Allergy and Infectious Diseases...Ingetrokken
-
National Institute of Allergy and Infectious Diseases...Ingetrokken